According to the latest study from BCC Research, "Chronic Disease Management: Therapeutics, Device Technologies, and Global ...
Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback